164 related articles for article (PubMed ID: 22403002)
1. PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker.
Yuzawa S; Kano MR; Einama T; Nishihara H
Med Oncol; 2012 Dec; 29(4):2824-30. PubMed ID: 22403002
[TBL] [Abstract][Full Text] [Related]
2. Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC.
Strell C; Norberg KJ; Mezheyeuski A; Schnittert J; Kuninty PR; Moro CF; Paulsson J; Schultz NA; Calatayud D; Löhr JM; Frings O; Verbeke CS; Heuchel RL; Prakash J; Johansen JS; Östman A
Br J Cancer; 2017 Jun; 117(1):65-77. PubMed ID: 28524160
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.
Suzuki S; Dobashi Y; Hatakeyama Y; Tajiri R; Fujimura T; Heldin CH; Ooi A
BMC Cancer; 2010 Nov; 10():659. PubMed ID: 21118571
[TBL] [Abstract][Full Text] [Related]
4. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CD90 (Thy-1) in pancreatic adenocarcinoma present in the tumor microenvironment.
Zhu J; Thakolwiboon S; Liu X; Zhang M; Lubman DM
PLoS One; 2014; 9(12):e115507. PubMed ID: 25536077
[TBL] [Abstract][Full Text] [Related]
6. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.
Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK
Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731
[TBL] [Abstract][Full Text] [Related]
8. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.
Erkan M; Michalski CW; Rieder S; Reiser-Erkan C; Abiatari I; Kolb A; Giese NA; Esposito I; Friess H; Kleeff J
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1155-61. PubMed ID: 18639493
[TBL] [Abstract][Full Text] [Related]
9. Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.
Hägglöf C; Hammarsten P; Josefsson A; Stattin P; Paulsson J; Bergh A; Ostman A
PLoS One; 2010 May; 5(5):e10747. PubMed ID: 20505768
[TBL] [Abstract][Full Text] [Related]
10. Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma.
Liu Z; Teng XY; Meng XP; Wang BS
World J Surg Oncol; 2014 Nov; 12():348. PubMed ID: 25407240
[TBL] [Abstract][Full Text] [Related]
11. SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma.
Khetan K; Baloda V; Sahoo RK; Vishnubhathla S; Yadav R; Saraya A; Sharma A; Gupta SD; Das P
Pathol Res Pract; 2019 Dec; 215(12):152685. PubMed ID: 31727501
[TBL] [Abstract][Full Text] [Related]
12. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
[TBL] [Abstract][Full Text] [Related]
13. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
14. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells.
Apte MV; Park S; Phillips PA; Santucci N; Goldstein D; Kumar RK; Ramm GA; Buchler M; Friess H; McCarroll JA; Keogh G; Merrett N; Pirola R; Wilson JS
Pancreas; 2004 Oct; 29(3):179-87. PubMed ID: 15367883
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma.
Patsouras D; Papaxoinis K; Kostakis A; Safioleas MC; Lazaris AC; Nicolopoulou-Stamati P
Mol Med Rep; 2015 Jun; 11(6):4585-90. PubMed ID: 25625587
[TBL] [Abstract][Full Text] [Related]
17. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
[TBL] [Abstract][Full Text] [Related]
18. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
19. A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma.
Zhang Y; Xu J; Hua J; Liu J; Liang C; Meng Q; Wei M; Zhang B; Yu X; Shi S
J Immunother Cancer; 2019 Aug; 7(1):233. PubMed ID: 31464648
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
